Yi Jiang

Dr. Yi Jiang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
YJYi Jiang
Yi Jiang
BWBangsheng Wu
Bangsheng Wu
LLLong Long
Long Long
JLJiaxing Li
Jiaxing Li
XJXiaoqing Jin
Xiaoqing Jin
Objectives The incidence of bystander cardiopulmonary resuscitation (CPR) is low in China. CPR training could improve public attitudes and willingness, but at present, the attitudes of the public after online training are unclear. This study investigated individual attitudes towards CPR, the willingness to perform it in emergencies along with the main obstacles and the overall effects of online training. Design Questionnaires were distributed to investigate the public attitudes and willingness towards performing bystander CPR. Setting Questionnaires were accessible after the online course ‘First Aid’. Participants 1888 students who attended ‘First Aid’ from December 2019 to 1 January 2020 and then completed the questionnaire voluntarily. Results The majority understood CPR (96.7%) and displayed a willingness to learn (98.4%) and to disseminate CPR knowledge (82.0%). Characteristics associated with more positive attitudes included women, the 26–35-year olds and those in medical-related occupations (p<0.05). Only 34.8% had CPR training before. Most people would willingly perform CPR on a close family member. Compared with the standard CPR (S-CPR), the public preferred chest compression-only CPR (CO-CPR) (p<0.01). The top three obstacles to performing CO-CPR were lack of confidence (26.7%), fear of harming the victim (23.4%) and causing legal trouble (20.7%), while regarding S-CPR, fear of disease transmission (22.9%) ranked second. Women, those in poor health and in medical-related occupations, were more likely to perform CPR (p<0.05). The confidence to perform CPR was improved remarkably after online training (p<0.05). Conclusions The overwhelming majority of respondents showed positive attitudes and willingness towards CPR. In some cases, there is still reluctance, especially towards S-CPR. Obstacles arise mainly due to lack of confidence in administering CPR, while online CPR training can markedly improve it. Therefore, we should focus on disseminating CPR knowledge, targeting those who are less willing to perform CPR and helping overcome their obstacles by online training.

2 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
YJYi Jiang
Yi Jiang
SDSai Dong
Sai Dong
YWYang Wang
Yang Wang
CD30 is overexpressed in many T-cell lymphoma (TCL) entities, including subsets of peripheral T-cell lymphomas (PTCL) and cutaneous T-cell lymphomas (CTCL). The antibody–drug conjugate brentuximab vedotin (BV), targeting CD30-positive cells, has been approved for the treatment of relapsed or refractory (R/R) systemic anaplastic large cell lymphoma (sALCL), and primary cutaneous anaplastic large cell lymphoma or mycosis fungoides in patients who have received previous systemic therapy. However, many patients still experience disease progression after BV monotherapy. Extensive efforts have been dedicated to investigating effective combinations of BV. A phase III clinical study demonstrated that the combination of BV with cyclophosphamide, doxorubicin, and prednisone (CHP) is superior to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) for CD30-positive PTCL. This study led to the approval of BV with CHP as the first-line therapy for CD30-positive PTCL (sALCL in Europe). We summarize the encouraging combination applications of BV in this review. Ongoing studies on combination therapies of BV are also listed, highlighting potential directions for the future application of BV. We focus on dissecting the underlying mechanisms of BV, discussing its effects on both tumor cells and the tumor microenvironment. Exploring resistance mechanisms in TCL provide valuable insights for optimizing BV-based therapies in the future.

14 October 2025 in British Journal of Dermatology
Verified
Journal Article
Closed access
PLPan Lai
Pan Lai
MCMengzhou Cao
Mengzhou Cao
MLMingjia Li
Mingjia Li
YJYi Jiang
Yi Jiang
YWYang Wang
Yang Wang
Evidence links severe atopic dermatitis (AD) to increased mycosis fungoides (MF) risk, yet the relationship remains debated due to overlapping clinical features, chronic Th2) inflammation and reports of dupilumab-associated cases of MF. By integrated analysis of single-cell RNA sequencing data from 47 skin lesions and multiplex immunofluorescence validation, we identified a distinct CD4+ T-cell subset in AD and MF, persisting after dupilumab treatment, and characterized by proliferative programmes and an IL-13-independent Th2-polarized phenotype with autonomous OX40–OX40L signalling. These results reveal a molecular continuum between AD and MF, offering mechanistic insights into their association and highlighting OX40/OX40L as potential targets in lymphomagenesis.